Esteban Javier Pérez Moreno
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Esteban Javier Pérez Moreno has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Andrés Felipe Mora-Salamanca
Grupo de Salud Materna y Perinatal, Instituto Nacional de Salud, Avenida Calle 26 No. 51-20—Zona 6 CAN, Bogotá 111321, Colombia
1 shared publication - Angélica Knudson
Departamento de Salud Pública, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia
1 shared publication - Angélica María González Clavijo
Universidad Nacional de Colombia, Bogotá, Colombia
1 shared publication - Brenda Stefania Pérez Mahecha
Departamento de Salud Pública, Facultad de Medicina Universidad Nacional de Colombia Bogotá Colombia
1 shared publication - Daniel Perilla-Roa1 shared publication
- Fredy Alexander Pazmiño
Affiliation Departamento de Salud Pública, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia
1 shared publication
Latest Publications
- 29 July 2022
- Published by Wiley in Tropical Medicine & International Health
- Vol. 27 (9) , 781-794
Prevalence of intestinal parasitism in preschool and school children in Colombia: Systematic review and meta‐analysis
Objective: Intestinal parasitic infections (IPIs) are a public health challenge in developing countries such as Colombia, causing anaemia and delayed growth and development in children. We aimed to estimate the geographical and prevalence trend of IPIs in the last 30 years in school and preschool children in Colombia.Methods: We conducted a systematic review and meta‐analysis. We identified potential manuscripts through PubMed, EMBASE, Web of Science, LILACS, Scielo and Google Scholar on the IPIs prevalence in school and preschool children in Colombia. Articles included in the qualitative analysis were published between 1990 and 2020 in English or Spanish and met the inclusion criteria. Subsequently, a random‐effects meta‐analysis, a meta‐regression and a trend analysis were performed.Results: We identified 2292 articles; 109 were included in the qualitative review, and 79 articles were included in the meta‐analysis. The estimated IPI prevalence was 55% (95% CI: 48–63). By age group, the prevalence in preschool children was 37% (95% CI: 26–49) and 66% (95% CI: 52–78) in schoolchildren. The prevalence by region was heterogeneous, with the Amazon being the highest (69%) and the Santanderes the lowest (28%). In the last 20 years, the prevalence of helminthiasis has decreased (from 64.66% in 1990–1995 to 22.09% in 2016–2020).Conclusion: The prevalence of IPIs is high (>30%) in three of the seven regions in Colombia. Biannual administration of mass deworming in schoolchildren is recommended in the Amazon region. Public policies aiming to control IPIs should be reinforced. Further prevalence studies should include Cesar, Guaviare, Vichada and Vaupés, where the epidemiology of IPIs is unknown.Sustainable Development Goals: Good health and wellbeing, clean water and sanitation, sustainable cities and communities.
- 29 July 2022
- Published by Wiley in Tropical Medicine & International Health
- Vol. 27 (9) , 781-794
Prevalence of intestinal parasitism in preschool and school children in Colombia: Systematic review and meta‐analysis
Objective: Intestinal parasitic infections (IPIs) are a public health challenge in developing countries such as Colombia, causing anaemia and delayed growth and development in children. We aimed to estimate the geographical and prevalence trend of IPIs in the last 30 years in school and preschool children in Colombia.Methods: We conducted a systematic review and meta‐analysis. We identified potential manuscripts through PubMed, EMBASE, Web of Science, LILACS, Scielo and Google Scholar on the IPIs prevalence in school and preschool children in Colombia. Articles included in the qualitative analysis were published between 1990 and 2020 in English or Spanish and met the inclusion criteria. Subsequently, a random‐effects meta‐analysis, a meta‐regression and a trend analysis were performed.Results: We identified 2292 articles; 109 were included in the qualitative review, and 79 articles were included in the meta‐analysis. The estimated IPI prevalence was 55% (95% CI: 48–63). By age group, the prevalence in preschool children was 37% (95% CI: 26–49) and 66% (95% CI: 52–78) in schoolchildren. The prevalence by region was heterogeneous, with the Amazon being the highest (69%) and the Santanderes the lowest (28%). In the last 20 years, the prevalence of helminthiasis has decreased (from 64.66% in 1990–1995 to 22.09% in 2016–2020).Conclusion: The prevalence of IPIs is high (>30%) in three of the seven regions in Colombia. Biannual administration of mass deworming in schoolchildren is recommended in the Amazon region. Public policies aiming to control IPIs should be reinforced. Further prevalence studies should include Cesar, Guaviare, Vichada and Vaupés, where the epidemiology of IPIs is unknown.Sustainable Development Goals: Good health and wellbeing, clean water and sanitation, sustainable cities and communities.
- Open Access
- 1 October 2020
- Published by Universidad Nacional de Colombia in Revista de la Facultad de Medicina
- Vol. 68 (4)
Uso de metformina y un inhibidor de SGLT2 en el manejo de lipodistrofia congénita generalizada. Reporte de caso
Introducción. La lipodistrofia congénita generalizada (LCG) es un síndrome genético autosómico recesivo extremadamente raro que se caracteriza por ausencia generalizada de tejido adiposo, deficiencia en la producción de hormonas como la leptina y complicaciones metabólicas potencialmente serias como diabetes mellitus tipo 2 (DM2), esteatohepatitis e hipertrigliceridemia.Presentación del caso. Paciente femenina de 17 años con un diagnóstico tardío de LCG y con diabetes mellitus (erróneamente clasificada como tipo I), hipertrigliceridemia severa e infecciones a repetición. Luego de introducir metformina y un inhibidor del SGLT2 en el manejo de la paciente, se logró un adecuado control metabólico.Conclusión. Con frecuencia, el desconocimiento de algunas enfermedades huérfanas lleva a diagnósticos erróneos y, por tanto, a tratamientos inadecuados que en algunos casos pueden empeorar la condición clínica de los pacientes. Por lo anterior, en el caso de la LCG, es necesario que la comunidad médica tenga una mejor comprensión de sus aspectos diagnósticos y terapéuticos para brindar un diagnóstico y tratamiento oportunos.
- 1 October 2020
- Published by Universidad Nacional de Colombia in Revista de la Facultad de Medicina
- Vol. 68 (4)
Open AccessUso de metformina y un inhibidor de SGLT2 en el manejo de lipodistrofia congénita generalizada. Reporte de caso
Introducción. La lipodistrofia congénita generalizada (LCG) es un síndrome genético autosómico recesivo extremadamente raro que se caracteriza por ausencia generalizada de tejido adiposo, deficiencia en la producción de hormonas como la leptina y complicaciones metabólicas potencialmente serias como diabetes mellitus tipo 2 (DM2), esteatohepatitis e hipertrigliceridemia.Presentación del caso. Paciente femenina de 17 años con un diagnóstico tardío de LCG y con diabetes mellitus (erróneamente clasificada como tipo I), hipertrigliceridemia severa e infecciones a repetición. Luego de introducir metformina y un inhibidor del SGLT2 en el manejo de la paciente, se logró un adecuado control metabólico.Conclusión. Con frecuencia, el desconocimiento de algunas enfermedades huérfanas lleva a diagnósticos erróneos y, por tanto, a tratamientos inadecuados que en algunos casos pueden empeorar la condición clínica de los pacientes. Por lo anterior, en el caso de la LCG, es necesario que la comunidad médica tenga una mejor comprensión de sus aspectos diagnósticos y terapéuticos para brindar un diagnóstico y tratamiento oportunos.